IFPMA: Pharmaceutical Industry Expresses Deep Disappointment With Decision on Waiving Intellectual Property Rights Adopted at the World Trade Organization Ministerial Conference

2022年06月21日 13:26:45 来自: (0)参与

IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken to adopt a TRIPS waiver, despite intellectual property (IP) not being a barrier to vaccine scale-up and wide acknowledgment of vaccines surplus.
IP has enabled the rapid research and development of several effective vaccines against COVID-19 and underpinned the more than 380 voluntary partnerships; while trade barriers have severely undermined collective efforts to deliver vaccines to those who need them most.
Industry warns that such an “empty shell” and fact-free decision can have severe consequences on innovation and global health security.

GENEVA--(BUSINESS WIRE)--Today’s decision at the World Trade Organization (WTO) Ministerial Conference (MC12) to endorse a TRIPS waiver for COVID-19 vaccines sends the wrong message to those carrying out research and development and innovating. It incorrectly points to intellectual property (IP) as a barrier to the pandemic response rather than an enabler bringing healthcare solutions, safely and quickly to patients.

IP has supported the fastest development and scale-up of safe and effective vaccines in history, with 13.9 billion COVID-19 vaccines produced to date. The IP framework has provided the basis for more than 380 voluntary partnerships for COVID-19 vaccines to be set up in record time, 88% of which involve technology transfer1.

Today’s decision sends a dangerous signal not only to the pharmaceutical industry but to all innovative sectors. Dismantling the very framework that has brought solutions to tackle COVID-19 and facilitated the unprecedented number of partnerships, voluntary licensing, and knowledge-sharing taking place during this pandemic can have ripple effects for the future.

Thomas Cueni, IFPMA Director-General, said: “The conversations on an intellectual property waiver have been challenging from the beginning, with disregard to evidence and facts. The decision is a disservice to the scientists that left no stone unturned and undermines manufacturing partnerships on every continent. The single biggest factor affecting vaccine scarcity is not intellectual property, but trade. This has not been fully addressed by the World Trade Organization”.

About IFPMA

IFPMA (https://www.ifpma.org/) represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

1 https://www.ifpma.org/resource-centre/research-based-biopharmaceutical-industry-on-the-trips-waiver-discussions-at-wto-ministerial-conference-mc12

相关新闻
淘宝网友:A monologue. 独白。
评论:好的文字是这样的:你写得不动声色,我看得肝肠寸断

网易网友:ミ支离破碎
评论:世界上最疼痛的话是:“我爱你,但是……”。世界上最甜蜜的话是:“……但是,我爱你”。

搜狐网友:解脱的诠释
评论:做女孩一定要经的起谎言,爱的起敷衍,忍的了欺骗,忘得了诺言,放的下一切,最后用笑来伪装你的泪眼!

猫扑网友:續寫這段情
评论:好名声是女人最体面的嫁妆。

其它网友:Curtain ( 落幕 )
评论:看我不顺眼的人,能给您心里添堵,我真是舒坦。

天涯网友:Flowers情调
评论:这世界上最爱我的男人,早已经从了妈妈。

天猫网友:Flowers ( 繁花 )
评论:如果你看到面前的阴影,别怕,那是因为你的背后有阳光!

本网网友:迩卜Sんī涐旳谁
评论:我也想做一个优雅的淑女,是生活把老娘逼成了泼妇.

凤凰网友:半日情obsessIOn
评论:当有人装B的时候、哥总是低下头。不是哥感到羞愧、而是哥在找砖头.

腾讯网友:她有我保护
评论:别以为遇见我就是你旳缘,也可能是你旳坎。

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin